Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Indaba Capital Management is a San Francisco-based investment management firm and SEC-registered investment adviser focused on event-driven and opportunistic value investing. The firm manages private pooled investment funds and managed accounts, typically investing across public-company equity and debt securities and often taking an activist or engagement-oriented approach with portfolio companies. Indaba is not a biotechnology, pharmaceutical, or healthcare operating company; rather, it is a financial services firm that may invest across sectors, including healthcare when relevant to its investment strategy. For biotech analyst purposes, it should be classified as an investor, not as a drug developer, platform biotech, CRO, CMO, or healthcare services operator.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Indaba Capital Management.